RecruitingNCT07725042

Analyses of Newly Diagnosed HIV Infection in Hong Kong

Combined Epidemiologic and Molecular Network Analyses of Newly Diagnosed HIV Infection in Hong Kong

Sponsor

Chinese University of Hong Kong

Enrollment

720 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

HIV-1-infection

Summary

The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is: \- what is the molecular pattern and burden of HIV-1 infections over the years

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with hiv-1-infection. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

S.H. Ho Research Centre for Infectious Diseases

North Point, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07725042

Related Trials

Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

NCT07683000

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

NCT0620313219 locations

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

NCT0747633910 locations

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

NCT076452873 locations

IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

NCT075968881 location